Effects of Intraoperative Hemoperfusion on Acute Kidney Injury After Aortic Dissection

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 206 participants.

Also called NCT05331495

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 206 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05331495
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05331495. Randomized; no masking; primary purpose treatment. Start 2022-04-20 (anticipated); primary completion 2024-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of Intraoperative Hemoperfusion on Acute Kidney Injury After Aortic Dissection
Acronym
EIHPOAKIAD
Intervention (Device)
Intraoperative Hemoperfusion
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University (class: other)

Record details

Record id
cardio:ct-nct05331495
Content hash
933516eb76fdc6b9c6db9dd31ee4f1fe3e1a41a5d74f60a6f9348f8f22776603